نتایج جستجو برای: blocking antibodies

تعداد نتایج: 206867  

Journal: :The Journal of Experimental Medicine 1995
V A Snewin S Premawansa G M Kapilananda L Ratnayaka P V Udagama D M Mattei E Khouri G Del Giudice J S Peiris K N Mendis P H David

One approach towards the development of a vaccine against malaria is to immunize against the parasite sexual stages that mediate transmission of the parasite from man to mosquito. Antibodies against these stages, ingested with the blood meal, inhibit the parasite development in the mosquito vector, constituting "transmission blocking immunity." Most epitopes involved in transmission-blocking im...

2016
Vesna Blazevic Maria Malm Daisuke Arinobu Suvi Lappalainen Timo Vesikari

Rotavirus (RV) and norovirus (NoV) are the 2 leading causes of acute viral gastroenteritis worldwide. We have developed a non-live NoV and RV vaccine candidate consisting of NoV virus-like particles (VLPs) and recombinant polymeric RV VP6 protein produced in baculovirus-insect cell expression system. Both components have been shown to induce strong potentially protective immune responses. As VP...

Journal: :Molecular cancer therapeutics 2014
Li Zhang Carla Castanaro Bo Luan Katie Yang Liangfen Fan Jeanette L Fairhurst Ashique Rafique Terra B Potocky Jing Shan Frank J Delfino Ergang Shi Tammy Huang Joel H Martin Gang Chen Douglas Macdonald John S Rudge Gavin Thurston Christopher Daly

EGFR blocking antibodies are approved for the treatment of colorectal cancer and head and neck squamous cell carcinoma (HNSCC). Although ERBB3 signaling has been proposed to limit the effectiveness of EGFR inhibitors, the underlying molecular mechanisms are not fully understood. To gain insight into these mechanisms, we generated potent blocking antibodies against ERBB3 (REGN1400) and EGFR (REG...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2015
W Hans Meisen Eric S Wohleb Alena Cristina Jaime-Ramirez Chelsea Bolyard Ji Young Yoo Luke Russell Jayson Hardcastle Samuel Dubin Kamaldeen Muili Jianhua Yu Michael Caligiuri Jonathan Godbout Balveen Kaur

PURPOSE Oncolytic herpes simplex viruses (oHSV) represent a promising therapy for glioblastoma (GBM), but their clinical success has been limited. Early innate immune responses to viral infection reduce oHSV replication, tumor destruction, and efficacy. Here, we characterized the antiviral effects of macrophages and microglia on viral therapy for GBM. EXPERIMENTAL DESIGN Quantitative flow cyt...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2013
Marieke F Fransen Tetje C van der Sluis Ferry Ossendorp Ramon Arens Cornelis J M Melief

PURPOSE Blockade of CTLA-4 by antibodies has potentiated antitumor T-cell responses in both preclinical models and clinical trials. However, treatment with CTLA-4 blocking antibodies is associated with autoimmune and inflammatory side effects. In this study, we propose a novel administration method for CTLA-4 blocking antibodies as monotherapy. EXPERIMENTAL DESIGN We use different preclinical...

Journal: :Annals of neurology 2012
Lukmanee Tradtrantip Hua Zhang Samira Saadoun Puay-Wah Phuan Chiwah Lam Marios C Papadopoulos Jeffrey L Bennett A S Verkman

OBJECTIVE Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of the central nervous system. Circulating autoantibodies (NMO-immunoglobulin [Ig]G) against astrocyte water channel aquaporin-4 (AQP4) cause complement- and cell-mediated astrocyte damage with consequent neuroinflammation and demyelination. Current NMO therapies, which have limited efficacy, include immunosuppression...

Journal: :American journal of clinical pathology 2016
Anndorie Cromar Bucky K Lozier Thomas R Haven Harry R Hill

OBJECTIVES Detection of acetylcholine receptor (AChR) blocking antibodies through the use of a radiolabel has become standard procedure in most laboratories. Known drawbacks associated with radioassay, including cost of radioisotopes, hazards to laboratory professionals, and manufacture and disposal of radioactive materials, have prompted investigation into replacement assays. We describe here ...

Journal: :Applied sciences 2021

Programmed death-ligand 1 (PD-L1) is a surface protein overexpressed in tumor cells. Recently, targeted therapy using PD-L1 antibodies to reconstitute the antitumor activity of T cells has received considerable attention as cancer treatment. Among several types anti-PD-L1 antibodies, small-sized antibody fragments are useful agents block for experimental and therapeutic purposes owing their hig...

A Khorasani , F Motamedi-Sedeh , H Mahravani , K Shafae ,

Background and Aims: The aim of this study was application of gamma irradiated FMDV antigen for liquid phase blocking sandwich ELISA (B-ELISA) to quantify guinea pig anti FMDV type A87/IRN antibody. Methods: FMDV type A87/IRN was propagated to a titer of 107.5/ml TCID50 and then irradiated by gamma irradiator. The irradiated 146 S antigen was purified by sucrose gradient centrifugation after in...

باصری , حمیدرضا, حضرتی تپه , خسرو , خشاوه, شهلا , عبایی, محمدرضا, محمدزاده حاجی پیرلو, حبیب, محمدی بوانی, مولود,

   Background & Aims: Malaria parasites attach to molecules on midgut surface of Anopheles mosquitoes to continue their life cycle. Here we try to evaluate the effect of anti-Anopheles midgut antibodies on coating these molecules and consequently blocking the transmission cycle of Plasmodium berghei inside their vectors. Materials & Methods: Balb/c mice were immunized with homogenized and degly...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید